PRVB - Provention Bio EPS beats by $0.07 misses on revenue November, 04 2021 07:05 AM Provention Bio Inc. Provention Bio (NASDAQ:PRVB): Q3 GAAP EPS of -$0.43 beats by $0.07. Revenue of $0.68M misses by $0.57M. Press Release For further details see: Provention Bio EPS beats by $0.07, misses on revenue